MT1DP and non-small cell lung carcinoma: MT1DP, a lncRNA, enhances erastin‐induced ferroptosis in non‐small cell lung cancer (NSCLC) by downregulating NRF2 through stabilizing miR‐365a‐3p, leading to increased reactive oxygen species (ROS), malondialdehyde (MDA), ferrous iron, and decreased glutathione (GSH).